Literature DB >> 3140583

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.

M G Hull1.   

Abstract

The frequency of polycystic ovarian disease (PCOD) as a cause of oligo-amenorrhea and infertility was determined, first by characterizing clinically occult PCOD using endocrinological methods, and secondly by estimating the frequency of overt and occult PCOD amongst infertile women residing in a particular area. Four groups of infertile women with oligo-amenorrhea due to 'functional' disorder were compared. The results show that by contrast with the groups having hyperprolactinemia or hypothalamic disorder the group with hirsutism (and therefore presumed PCOD) was closely resembled by a non-hirsute group in terms of estrogenization, LH level, LH/FSH ratio, prolactin level, body mass and responsiveness to clomiphene. The last group was therefore concluded to have a mild occult form of PCOD. The population studies revealed, first, that overt and occult PCOD accounted for 90% of patients with oligomenorrhea and 37% with amenorrhea, or 73% with oligo- or amenorrhea. Oligo- or amenorrhea accounted for 21% of couples with infertility and the annual incidence was 247 patients per million of the general population. The annual incidence of infertility due to PCOD per million was 41 with overt PCOD and 139 with occult PCOD (total 180). Of those, 140 appeared to respond well to clomiphene (78%) but 40 (22%) failed, requiring alternative therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3140583     DOI: 10.3109/09513598709023610

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  63 in total

1.  The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.

Authors:  Richard S Legro; Allen R Kunselman; Robert G Brzyski; Peter R Casson; Michael P Diamond; William D Schlaff; Gregory M Christman; Christos Coutifaris; Hugh S Taylor; Esther Eisenberg; Nanette Santoro; Heping Zhang
Journal:  Contemp Clin Trials       Date:  2012-01-13       Impact factor: 2.226

2.  Comparison of effects of different statins on growth and steroidogenesis of rat ovarian theca-interstitial cells.

Authors:  Anna Sokalska; Scott D Stanley; Jesus A Villanueva; Israel Ortega; Antoni J Duleba
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

3.  Birth weight and childhood growth in daughters of women with irregular menstrual cycles.

Authors:  Erica T Wang; Piera M Cirillo; Chia-Ning Kao; Barbara A Cohn; Marcelle I Cedars
Journal:  Gynecol Endocrinol       Date:  2013-06       Impact factor: 2.260

Review 4.  The treatment of patients with polycystic ovaries undergoing IVF.

Authors:  S Franks
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

Review 5.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

6.  Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study.

Authors:  Giuseppe Loverro; Giovanni De Pergola; Edoardo Di Naro; Massimo Tartagni; Cristina Lavopa; Anna Maria Caringella
Journal:  J Ovarian Res       Date:  2010-11-09       Impact factor: 4.234

Review 7.  Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS.

Authors:  Supat Sinawat; Pranom Buppasiri; Pisake Lumbiganon; Porjai Pattanittum
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

8.  Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility.

Authors:  Jorge E Chavarro; Janet W Rich-Edwards; Bernard A Rosner; Walter C Willett
Journal:  Epidemiology       Date:  2009-05       Impact factor: 4.822

9.  Bone mineral density in hyperandrogenic amenorrhoea.

Authors:  J Prezelj; A Kocijancic
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

10.  Current trends in the treatment of polycystic ovary syndrome with desire for children.

Authors:  Margalida E Sastre; Maria O Prat; Miguel Angel Checa; Ramon C Carreras
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.